Abstract
Hepatic peroxisomes were studied by morphometric and immunocytochemical techniques in control patients and in four Zellweger syndrome patients, two infantile Refsum's (IRD) patients, one neonatal adrenoleukodystrophy (NALD) patient, and three patients with peroxisomal disorders (PD) which do not fit any currently recognised classification, but have disorders involving a defect in peroxisomal biogenesis. Peroxisomes which were ultrastructurally abnormal and greatly reduced in size and/or number were found in two of the Zellweger syndrome patients, and the NALD and IRD patients. There was variation in their numerical density ranging from none at all in two of the Zellweger syndrome patients to normal numbers in the IRD patients. In most patients there was a decrease in the immunolabelling of catalase over the peroxisomes. In the Zellweger syndrome and NALD patients, the small, abnormal peroxisomes did not label for any of the Β-oxidation proteins. The IRD patients and the PD patients however, were heterogeneous with respect to Β-oxidation labelling. The ultrastructural heterogenity of peroxisomes in these peroxisomal disorders patients indicates there may be genotypic differences between the major groups and also within each group. The common factor in all the patients in this study where peroxisomes were present was the presence in the hepatic peroxisomes of an electron dense centre which did not label immunocytochemically for catalase or the Β-oxidation enzymes. This electron dense centre may indicate a structural abnormality in the peroxisomes in these patients.
Similar content being viewed by others
References
Aikawa J, Ishizawa S, Narisawa K, Tada K, Yokota S, Hashimoto T (1987) The abnormality of peroxisomal membrane proteins in Zellweger syndrome. J Inherited Metab Dis 10 [Suppl 2] 211–213
Balfe A, Hoefler G, Chen WW, Watkins PA (1990) Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata. Pediatr Res 27:304–310
Beard ME, Moser AB, Sapirstein V, Holtzman E (1986) Peroxisomes in infantile phytanic acid storage disease: a cytochemical study in skin fibroblasts. J Inherited Metab Dis 9:321–334
Brul S, Westerveld A, Strijland A, Wanders RJA, Schram AW, Heymans HSA, Schutgens RBH, Van Den Bosch H, Tager JM (1988) Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. J Clin Invest 81:1710–1715
Chen N, Crane DI (1992) Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators. Biochem J 283:605–610
De Craemer D, Zweens MJ, Lyonnet S, Wanders RJA, Poll-The BT, Schutgens RBH, Waelkens JJJ, Saudubray JM, Roels F (1991) Very large peroxisomes in distinct peroxisomal disorders (rhizomelic chondrodysplasia punctata and acyl-CoA oxidase deficiency): novel data. Virchows Arch [A] 419:523–525
Espeel M, Hashimoto T, De Craemer D, Roels F (1990a) Immunocytochemical detection of peroxisomal Β-oxidation enzymes in cryostat and paraffin sections of human post-mortem liver. HistochemJ 22:57–62
Espeel M, Jauniaux E, Hashimoto T, Roels F (1990b) Immunocytochemical localization of peroxisomal Β-oxidation enzymes in human fetal liver. Prenat Diagn 10:349–357
Gartner J, Moser HW, Valle D (1992) Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nature genetics 1:16–23
Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973) Peroxisomal and mitochondrial defects in the cerebrohepato-renal syndrome. Science 182:62–64
Goldfischer S, Collins J, Rapin I, Coltoff-Schiller B, Chang C, Nigro M, Black V, Javitt N, Moser H, Lazarow P (1985) Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science 227:67–70
Heikoop JC, Van den Berg M, Strijland A, Weijers PJ, Just WW, Meijer AJ, Tager JM (1992) Turnover of peroxisomal vesicles by autophagic proteolysis in cultured fibroblasts from Zellweger syndrome patients. Eur J Cell Biol 57:165–171
Hughes JL, Poulos A, Robertson E, Chow CW, Sheffield LJ, Christodoulou J, Carter RF (1990) Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders. Virchows Arch [A] 416:255–264
Hughes JL, Poulos A, Crane DI, Chow CW, Sheffield LJ, Sillence D (1992) Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata. Eur J Pediatr 151:829–836
Hughes JL, Bourne AJ, Poulos A (1993) Establishment of a normal range of morphometric values for peroxisomes in pediatric liver. Virchows Arch [A] 423:453–457
Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T (1990) The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J Biol Chem 265:4534–4540
Litwin JA, Beier K (1988) Immunogold localization of peroxisomal enzymes in Epon-embedded liver tissue. Histochemistry 88:193–196
Litwin JA, Völkl A, Müller-Höcker J, Hashimoto T, Fahimi HD (1987) Immunocytochemical localization of peroxisomal enzymes in human liver biopsies. Am J Pathol 128:141–150
Moser HW, Bergin A, Cornblath D (1991) Peroxisomal disorders. Biochem Cell Biol 69:463–474
Poll-The, Skjeldal OH Stokke O, Poulos A, Demaugre F, Saudubray J-M (1989) Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Hum Genet 81:175–181
Poulos A, Sharp P, Feilenberg AJ, Johnson DW (1988) Accumulation of pristanic acid (2, 6, 10, 14 tetramethyl-pentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction. Eur J Pediatr 147:143–147
Robertson EF, Poulos A, Sharp P, Manson J, Wise G, Jaunzems A, Carter R (1988) Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years. Eur J Pediatr 147:133–142
Roels F, Cornelis A, Poll-Thé BT, Aubourg P, Ogier H, Scotto J, Saudubray JM (1986) Hepatic peroxisomes are deficient in infantile Refsum disease: a cytochemical study of 4 cases. Am J Med Genet 25:257–271
Roscher AA, Hoefler S, Hoefler G, Paschke E, Paltauf F, Moser A Moser H (1989) Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis- a complementation study involving cell lines from 19 patients. Pediatr Res 26:67–72
Santos MJ, Imanaka T, Shio H, Small GM, Lazarow PB (1988a) Peroxisomal membrane ghosts in Zellweger syndrome- aberrant organelle assembly. Science 239:1536–1538
Santos MJ, Imanaka T, Shio H, Lazarow PB (1988b) Peroxisomal integral membrane proteins in control and Zellweger fibroblasts. J Biol Chem 263:10501–10509
Small GM, Santos MJ, Imanaka T, Poulos A, Danks DM, Moser HW, Lazarow PB (1988) Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy. J Inherited Metab Dis 11:358–371
Suzuki Y, Shimozawa N, Orii T, Aikawa J, Tada K, Kuwabara T, Hashimoto (1987) Biosynthesis of peroxisomal membrane polypeptides in infants with Zellweger syndrome. J Inherited Metab Dis 10:297–300
Vamecq J, Draye JP, Van Hoof 0F, Misson JP, Evrard P, Vereuen G, Eyssen HJ, Van Eldere J, Schutgens RBH, Wanders RJA, Roels F, Goldfischer S (1986) Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy. Am J Pathol 125:524–535
Wanders RJA, Van Roermund CWT, Schutgens RBH, Tager JM (1991) Disorders of peroxisomal fatty acid Β-oxidation. In: Inborn errors of metabolism. Schaub J, Van Hoof F, Vis HL (eds) Nestlé Nutrition Workshop Series 24, Vevey/Raven Press New York, pp 43–56
Weibel ER (1979) “Stereological methods”, vol 1. Practical methods for biological morphometry. Academic Press, London
Wiemer EAC, Brul S, Just WW, Van Driel R, Brouwer-Kelder E, Van Den Berg M, Weijers PJ, Schutgens RBH, Van Den Bosch H, Schram A, Wanders RJA, Tager JM (1989) Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts. Eur J Cell Biol 50:407–417
Wiemer EAC, Out M, Schelen A, Wanders RJA, Schutgens RBH, Van Den Bosch H, Tager JM (1991) Phenotypic heterogeneity in cultured skin fibroblasts from patients with disorders of peroxisome biogenesis belonging to the same complementation group. Biochem Biophys Acta 1097:232–237
Wilson GN (1991) Structure-function relationships in the peroxisome: implications for human disease. Biochem Med Metab Biol 46:288–298
Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T, Fujiki Y, Osumi T, Hashimoto T, Moser HW (1992) Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet 88:491–499
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hughes, J.L., Crane, D.I., Robertson, E. et al. Morphometry of peroxisomes and immunolocalisation of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Vichows Archiv A Pathol Anat 423, 459–468 (1993). https://doi.org/10.1007/BF01606536
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01606536